Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.81
+0.05503.14%
Volume:93.99K
Turnover:169.43K
Market Cap:76.79M
PE:-1.01
High:1.83
Open:1.76
Low:1.76
Close:1.75
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:0.76
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-18.05
PE(LYR):-1.29

Loading ...

Annovis Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 15

Annovis Bio Q1 EPS $(0.63) Misses $(0.40) Estimate

Benzinga Earnings
·
May 15

Annovis Bio Inc - Cash and Cash Equivalents $14.2 Mln as of March 31, 2026

THOMSON REUTERS
·
May 15

Press Release: Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 15

Annovis Bio Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
May 08

Annovis Bio CEO presents multi-protein Alzheimer’s model at Fierce Biotech Week 2026

Reuters
·
May 07

Annovis Bio announces annual shareholder meeting

Reuters
·
May 01

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio

GlobeNewswire
·
Apr 28

Annovis Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 14

Annovis Bio raises USD 10 million in underwritten public offering

Reuters
·
Apr 10

Annovis Bio Prices Registered Direct Offering to Fund Trials

TIPRANKS
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

BRIEF-Annovis Announces $10 Million Underwritten Offering Of Common Stock And Accompanying Warrants

Reuters
·
Apr 09

Annovis Bio prices USD 10 million stock offering with warrants at USD 1.9 unit

Reuters
·
Apr 09

Annovis Bio Inc - Combined Offering Price per Share and Warrant Is $1.90

THOMSON REUTERS
·
Apr 09

Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants

GlobeNewswire
·
Apr 09

Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio

TIPRANKS
·
Apr 04

Annovis Bio director Michael B. Hoffman buys $1.5 million common shares

Reuters
·
Apr 04

Annovis Bio wins U.S. patent for buntanetap to treat brain infection-related injuries

Reuters
·
Apr 02

Annovis Publishes Historical Review of Buntanetap in The Scientist

GlobeNewswire
·
Mar 31